International News Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International News Ledger.

Press releases published on November 5, 2026

an hour ago

Stress Isn't Always About What's Happening Right Now

Indeterminate GlobeNewswire

an hour ago

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Duolingo, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DUOL

Indeterminate GlobeNewswire

an hour ago

Beyond Meat® Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

an hour ago

HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Reminds Better Home & Finance (NASDAQ: BETR) Investors of Class Action and November 20, 2026 Lead Plaintiff Deadline

Indeterminate GlobeNewswire

an hour ago

Step Pharma to present data from ongoing phase 2 clinical trial of dencatistat in essential thrombocythaemia at 68th ASH Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

ROSEN, A LEADING LAW FIRM, Encourages Coastal Financial Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CCB

Indeterminate GlobeNewswire

2 hours ago

LKQ Investor News: If You Have Suffered Losses in LKQ Corporation, You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire

2 hours ago

Heartland Express, Inc. Announces Participation in Upcoming Conference

Indeterminate GlobeNewswire

2 hours ago

Use Of Ryoncil First Line After Steroids For Pediatric Acute Graft Versus Host Disease Highlighted In Key Opinion Leader Webinar

Indeterminate GlobeNewswire

2 hours ago

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Ensign Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ENSG

Indeterminate GlobeNewswire

2 hours ago

MedVirtual Highlights the Human Advantage in Healthcare Staffing Amid the Rise of AI Alternatives

Indeterminate GlobeNewswire

2 hours ago

HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia

Indeterminate GlobeNewswire

2 hours ago

TaiMed Biologics to Present 24-Week Phase 2a Data on TMB-365/TMB-380 Maintenance Regimen at HIV Glasgow 2026

Indeterminate GlobeNewswire